[1] Prince M. Progress on dementia: leaving no one behind[J]. The Lancet, 390, e51-e53(2017).

[2] Adlard P A, Tran B A, Finkelstein D I et al. A review of β-amyloid neuroimaging in Alzheimer's disease[J]. Frontiers in Neuroscience, 8, 327(2014).

[3] Schnabel J. Amyloid: little proteins, big clues[J]. Nature, 475, S12-S14(2011).

[4] Dong J H, Revilla-Sanchez R, Moss S et al. Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease[J]. Neuropharmacology, 59, 268-275(2010).

[5] Ji M B, Arbel M, Zhang L L et al. 4(11): eaat7715(2018).

[6] Celli J P, Spring B Q, Rizvi I et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization[J]. Chemical Reviews, 110, 2795-2838(2010).

[7] Cheng L, Wang C, Feng L Z et al. Functional nanomaterials for phototherapies of cancer[J]. Chemical Reviews, 114, 10869-10939(2014).

[8] Lan S Y, Zhang D, Liu X L et al. Tumor-microenvironment activable smart nanocarrier system for photodynamic therapy of cancers[J]. Chinese Journal of Lasers, 45, 0207008(2018).

[9] Zhang J Y. Study on detection and aggregation inhibition of amyloid β based on nanomaterials[D]. Shanghai: East China Normal University(2016).

[10] Ahn M, Lee B I, Chia S et al. Chemical and mechanistic analysis of photodynamic inhibition of Alzheimer's β-amyloid aggregation[J]. Chemical Communications, 55, 1152-1155(2019).

[11] Lee B I, Suh Y S, Chung Y J et al. Shedding light on Alzheimer's β-amyloidosis: photosensitized methylene blue inhibits self-assembly of β-amyloid peptides and disintegrates their aggregates[J]. Scientific Reports, 7, 7523(2017).

[12] Zhao Y M, Liu C C, Wang J et al. Research progress on photodynamic antimicrobial chemotherapy based on rare earth upconversion nanoplatform[J]. Chinese Journal of Lasers, 45, 0207013(2018).

[13] Johansson P K, Koelsch P. Label-free imaging of amyloids using their intrinsic linear and nonlinear optical properties[J]. Biomedical Optics Express, 8, 743-756(2017).

[14] Whittingham J L, Scott D J, Chance K et al. Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation[J]. Journal of Molecular Biology, 318, 479-490(2002).

[15] Esler W P, Stimson E R, Jennings J M et al. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism[J]. Biochemistry, 39, 6288-6295(2000).

[16] Andersen C B, Yagi H, Manno M et al. Branching in amyloid fibril growth[J]. Biophysical Journal, 96, 1529-1536(2009).

[17] Exley C, House E, Collingwood J et al. Spherulites of Aβ42in vitro and in Alzheimer's disease[J]. Nature Precedings(2009).

[18] Zhang Y J, Shi J M, Bai C J et al. Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay[J]. Journal of Biological Chemistry, 287, 748-756(2012).

[19] del Mercato L L, Pompa P P, Maruccio G et al. Charge transport and intrinsic fluorescence in amyloid-like fibrils[J]. Proceedings of the National Academy of Sciences, 104, 18019-18024(2007).

[20] Hanczyc P, Samoc M, Norden B. Multiphoton absorption in amyloid protein fibres[J]. Nature Photonics, 7, 969-972(2013).

[21] Zhang J, Liu J, Zhu Y et al. Photodynamic micelles for amyloid β degradation and aggregation inhibition[J]. Chemical Communications, 52, 12044-12047(2016).